tirzepatide phase 3 study results after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 trial Phase 3 randomized controlled clinical

Like GLP-1, it helps your pancreas release insulin and communicates with your brain to affect appetite

However, future clinical applications may be limited by the somewhat narrow spectrum of activity and limited efficacy of the parent drug 6-MP

This article helps you evaluate both options against clinical evidence and your own health context, including how genetic factors may inform your medication selection process

Effects of GLP-1RAs on Appetite, Satiety and Hunger, and Gastric Emptying GLP-1RAs are attractive agents for the management of obesity owing to the actions of GLP-1 on appetite and energy intake

Additionally, its once-weekly administration and FDA approvals for obesity management helped bolster its position in the market